Protalix BioTherapeutics
PLX
#8915
Rank
ยฃ0.10 B
Marketcap
ยฃ1.30
Share price
-1.14%
Change (1 day)
-2.11%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: ยฃ0.10 Billion

As of December 2025 Protalix BioTherapeutics has a market cap of ยฃ0.10 Billion. This makes Protalix BioTherapeutics the world's 8915th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ0.10 B-2.81%
2024ยฃ0.10 B5.35%
2023ยฃ0.10 B77.65%
2022ยฃ57.37 M104.4%
2021ยฃ28.06 M-68.38%
2020ยฃ88.77 M139.2%
2019ยฃ37.11 M2.09%
2018ยฃ36.35 M-46.82%
2017ยฃ68.35 M53.14%
2016ยฃ44.63 M-35.02%
2015ยฃ68.69 M-37.9%
2014ยฃ0.11 B-49.82%
2013ยฃ0.22 B-26.56%
2012ยฃ0.30 B10.54%
2011ยฃ0.27 B-48.04%
2010ยฃ0.52 B58.03%
2009ยฃ0.33 B246.93%
2008ยฃ95.32 M-26.49%
2007ยฃ0.12 B-75.38%
2006ยฃ0.52 B3565.49%
2005ยฃ14.37 M4631.43%
2004ยฃ0.3 M-53.41%
2003ยฃ0.65 M225.94%
2002ยฃ0.2 M-56.75%
2001ยฃ0.46 M-6.16%
2000ยฃ0.49 M-0.23%
1999ยฃ0.49 M-85.63%
1998ยฃ3.43 M-75.39%
1997ยฃ13.96 M

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Protalix BioTherapeutics was reported to be:

ยฃ0.10 Billion
by Nasdaq info icon info icon
ยฃ0.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amicus Therapeutics
FOLD
ยฃ2.29 B 2,095.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ11.63 B 11,044.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ111.01 B 106,275.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.49 B 23,368.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel